KDR and neoplasm: Consequently, EVs modulate the angiogenesis mechanism through the activation of vascular endothelial growth factor receptor-2 (VEGFR-2), which promotes the migration of ECs towards the cluster of mutant cells and leads to the formation of new blood vessels by providing nutrients to support cancerogenesis and growth of the tumor mass [20,21].